Full text is available at the source.
Abstract
Konjac glucomannan (KGM) significantly reduces blood lipids and intestinal lipid accumulation compared to degradation products in obese mice.
- KGM inhibits intestinal lipid absorption and output more effectively than its degradation products.
- KGM and its degradation products downregulated certain intestinal gene expressions associated with lipid uptake.
- KGM enhanced the intestinal barrier and influenced gut microbiota composition more than degradation products.
- KGM and its degradation products correlated with changes in gut microbiota linked to lipid absorption.
- The mechanism involves the viscosity effects and modulation of intestinal activities related to lipid processing.
Simplified